Nervgen Pharma To Participate At Upcoming Investor Conferences
18 Feb 2026 //
GLOBENEWSWIRE
NervGen Announces Retirement of CFO, Bill Adams
12 Feb 2026 //
GLOBENEWSWIRE
NervGen Pharma Presents At Unite2Fight Paralysis Symposium
11 Feb 2026 //
GLOBENEWSWIRE
Nervgen Pharma Names Adam Rogers Ceo For Spinal Cord Injury
09 Feb 2026 //
GLOBENEWSWIRE
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22
20 Jan 2026 //
GLOBENEWSWIRE
NervGen Pharma Begins Trading On Nasdaq Today
08 Jan 2026 //
GLOBENEWSWIRE
NervGen Peptide Demonstrates Nerve Repair in Phase II SCI Trial
24 Nov 2025 //
BIOSPACE
NervGen Reports Ph1b/2a NVG-291 Data In Spinal Cord Injury
02 Jun 2025 //
GLOBENEWSWIRE
NervGen Pharma to Host Virtual Investor Event
25 Mar 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support